Switzerland · Series A startup

Who invested in Lyfegen

One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Hardware & ElectronicsHealthcare

Funding summaryUpdated 26 Oct 2026

$5.7Mraised across 1 round since 2024, from 2 sources

Latest round
Series A, $5.7MDec 2024
Led by
TX Ventures
Investors
4 (1 led)
See who backed them

The rounds

  1. Dec 2024
    Series A$5.7M

    Reported by Firms' own news pages and 1 other

Founders and team

From Lyfegen's own website: 3 founders, 4 on the team.

Girisha FernandoFounder & CEO
Michel MohlerCFO & Founder
Nico MrosCXO & Founder
  • Andrei GhiordunHead of Technology
  • Anca MarinBusiness Analyst
  • Filiberto BecerraMarketing Manager​
  • Mihaela BoianTalent Manager

Everyone who backed them

TX VenturesVC firm1round, led 1
MassChallengeAccelerator1round
InnosuisseGovernment1round
aMoonGrowth equity1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Lyfegen

Who invested in Lyfegen?

Lyfegen's investors include TX Ventures, MassChallenge, Innosuisse and aMoon. TX Ventures led its latest round.

How much has Lyfegen raised?

Lyfegen has raised $5.7M across 1 round since 2024.

When did Lyfegen last raise?

Lyfegen's most recent round was a Series A of $5.7M in Dec 2024, led by TX Ventures.

What was Lyfegen's biggest round?

Its most recent round, $5.7M in Dec 2024, is also its largest on record.

Who backed Lyfegen first?

Lyfegen's first round on record, in Dec 2024, was backed by TX Ventures, MassChallenge and Innosuisse and 1 others.

What stage is Lyfegen at?

Lyfegen's latest named round is a Series A, in Dec 2024.

Where is Lyfegen based?

Lyfegen is based in Switzerland.

Who led Lyfegen's rounds?

TX Ventures led the Series A in 2024.

Companies like Lyfegen

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.